The all-stock $18 billion merger between Towers Watson and Willis Group Holdings is a bad deal according to some Towers Watson shareholders.
Also see: What does the Willis, Towers Watson merger mean about the health care industry?
More From Employee Benefit News
Voluntary benefits litigation spotlights disclosure
Experts suggest that process and disclosure matter more than ever in the face of class-action lawsuits alleging overpayments on voluntary benefits premiums.
Willis Towers Watson reveals that employers plan to boost retirement benefits this year
As employers anticipate challenges with hiring and retaining their workforce, they’re looking at ways to enhance their retirement plans to stand out from the crowd.
What the OSHA vaccine mandate could mean for America’s workforce
Two experts delve into how the OSHA vaccine mandate will affect employers and employees across the U.S.
Willis Towers Watson launches AI-driven software to help employers reinvent jobs
With the new software, employers can analyze work at a task level, identify what work can be performed remotely and better adapt to changing business needs.
Alera Group M&A heats up with 2 new benefits acquisitions
Industry consolidation has been on the rise as the role of private-equity and other financial institution-backed buyers expands.
